Meret Gaugler, PhD, joins Page Therapeutics as independent member of the Board of Directors

BASEL, Switzerland, Oct. 25, 2024 /PRNewswire/ — Page Therapeutics, a biotech company focused on tackling metastatic cancer spread at its root, is pleased to announce the appointment of Meret Gaugler, PhD, as independent member of the Board of Directors. Dr. Gaugler comes with both a…